Nadège Gaborit
- Oncology top 10%
- HER2/EGFR in Cancer Research 15
- Pancreatic and Hepatic Oncology Research 3
-
- Monoclonal and Polyclonal Antibodies Research 11
-
- Glycosylation and Glycoproteins Research 2
-
- Healthcare and Venom Research 3
-
- Lung Cancer Treatments and Mutations 3
-
- Toxin Mechanisms and Immunotoxins 3
-
- Chronic Lymphocytic Leukemia Research 2
Nadège Gaborit
23 papers receiving 757 citations
Peers
Comparison fields: 5 of 73
- Oncology 449
- Radiology, Nuclear Medicine and Imaging 264
- Molecular Biology 370
- Immunology and Allergy 32
- Equine 8
Countries citing papers authored by Nadège Gaborit
This map shows the geographic impact of Nadège Gaborit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Gaborit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Gaborit more than expected).
Fields of papers citing papers by Nadège Gaborit
This network shows the impact of papers produced by Nadège Gaborit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Gaborit. The network helps show where Nadège Gaborit may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nadège Gaborit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 3 | |
| 2 | 2020 | 40 | |
| 3 | 2019 | 20 | |
| 4 | 2018 | 43 | |
| 5 | 2017 | 13 | |
| 6 | 2017 | 42 | |
| 7 | 2015 | 35 | |
| 8 | 2015 | 0 | |
| 9 | 2015 | 18 | |
| 10 | 2014 | 38 | |
| 11 | 2013 | 93 | |
| 12 | 2013 | 35 | |
| 13 | 2012 | 21 | |
| 14 | 2012 | 60 | |
| 15 | 2011 | 58 | |
| 16 | 2006 | 7 | |
| 17 | 2006 | 56 | |
| 18 | 2004 | 11 | |
| 19 | 2004 | 32 | |
| 20 | 2003 | 9 |
About Nadège Gaborit
Nadège Gaborit is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 24 papers that have together received 773 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Pancreatic and Hepatic Oncology Research (3 papers), Healthcare and Venom Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (449 citations), Radiology, Nuclear Medicine and Imaging (264 citations) and Molecular Biology (370 citations). Nadège Gaborit has collaborated with scholars based in France, Israel and Slovakia. Frequent co-authors include Moshit Lindzen, Yosef Yarden, André Pèlegrin, Christel Larbouret, Thierry Chardès, D. Azria, Pierre Gillet, Caroline Mollévi, Laurent Grossin and Patrick Netter. Their work appears in journals such as Neoplasia, Proceedings of the National Academy of Sciences, Human Vaccines & Immunotherapeutics, FEBS Journal and EMBO Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.